The experimental coronavirus treatment remdesivir has failed in its first randomized clinical trial, inadvertently released results showed on Thursday, dampening expectations for the closely watched drug.
A draft summary went online briefly on the WHO Web site and was first reported by the Financial Times and health news Web site Stat, which posted a screenshot.
However, Gilead Sciences, the company behind the medicine, disputed how the now-deleted post had characterized the findings, saying that the data showed a “potential benefit.”
Photo: AFP
The Chinese trial involved 237 patients, with 158 on the drug and 79 in a control group, the summary said, adding that remdesivir was stopped early in 18 patients because of side effects.
The authors said that remdesivir was “not associated with a difference in time to clinical improvement” compared with the control.
After a month, 13.9 percent of the patients on remdesivir had died, compared with 12.8 percent of those in the control group. The difference is not statistically significant.
The WHO told the Financial Times that the draft is undergoing peer review and was published early in error.
“We believe the post included inappropriate characterizations of the study,” a Gilead spokesman told reporters, adding that it was terminated early due to low enrollment and was therefore not statistically meaningful.
“As such, the study results are inconclusive, though trends in the data suggest a potential benefit for remdesivir, particularly among patients treated early in disease,” the spokesman said.
The study does not represent the final word on the matter, and there are several large-scale trials in advanced stages that should soon provide a clearer picture.
Remdesivir, which is administered intravenously, was among the first drugs suggested as a treatment for the novel coronavirus and as such has great hopes riding on it.
Last week, Stat reported that it had shown significant efficacy at a Chicago hospital where patients who are part of one of the major trials are being treated.
The US National Institutes of Health also reported it that had proven effective in a small experiment on monkeys.
Remdesivir, which previously failed in trials against Ebola, belongs to a class of drugs that act on the virus directly — as opposed to controlling the abnormal and often lethal autoimmune response it causes. It mimics one of the four building blocks of RNA and DNA, and gets absorbed into the virus’ genome, which in turn stops the pathogen from replicating.
Anti-malarial drugs hydroxychloroquine and chloroquine have also been widely used on COVID-19 on a so-called “compassionate basis” pending results from large trials, with early studies decidedly mixed.
Other therapies that are being studied include collecting antibodies from COVID-19 survivors and injecting them in patients, or harvesting antibodies from genetically engineered mice that were deliberately infected.
Separately in France, new research shows that nicotine could protect people from contracting COVID-19.
The findings came after researchers at a top Paris hospital examined 343 COVID-19 patients, as well as 139 people with the illness who had milder symptoms.
They found that a low number of them smoked, compared with smoking rates of about 35 percent in France’s general population.
“Among these patients, only 5 percent were smokers,” said Zahir Amoura, the study’s coauthor and a professor of internal medicine.
The research echoed similar findings published in the New England Journal of Medicine last month suggesting that 12.6 percent of 1,000 people infected in China were smokers.
That was a much lower figure than the number of regular smokers in China’s general population, about 26 percent, WHO data showed.
The theory is that nicotine could adhere to cell receptors, therefore blocking the novel coronavirus from entering cells and spreading in the body, said neurobiologist Jean-Pierre Changeux from France’s Pasteur Institute, who also coauthored the study.
The researchers are awaiting approval from health authorities to carry out further clinical trials.
The researchers are looking into whether nicotine could help to prevent “cytokine storms,” a rapid overreaction of the immune system that scientists think could play a key role in fatal COVID-19 cases.
However, with further research needed, experts are not encouraging people to pick up smoking or use nicotine patches as a protective measure against the virus.
“We must not forget the harmful effects of nicotine,” French Director-General for Health Jerome Salomon said.
“Those who do not smoke should absolutely not use nicotine substitutes,” which cause side effects and addiction, he said.
A ship that appears to be taking on the identity of a scrapped gas carrier exited the Strait of Hormuz on Friday, showing how strategies to get through the waterway are evolving as the Middle East war progresses. The vessel identifying as liquefied natural gas (LNG) carrier Jamal left the Strait on Friday morning, ship-tracking data show. However, the same tanker was also recorded as having beached at an Indian demolition yard in October last year, where it is being broken up, according to market participants and port agent’s reports. The ship claiming to be Jamal is likely a zombie vessel that
Japan is to downgrade its description of ties with China from “one of its most important” in an annual diplomatic report, according to a draft reviewed by Reuters, as relations with Beijing worsen. This year’s Diplomatic Bluebook, which Japanese Prime Minister Sanae Takaichi’s government is expected to approve next month, would instead describe China as an important neighbor and the relationship as “strategic” and “mutually beneficial.” The draft cites a series of confrontations with Beijing over the past year, including export controls on rare earths, radar lock-ons targeting Japanese military aircraft and increased pressure around Taiwan. The shift in tone underscores a deterioration
LAW CONSTRAINTS: The US has been pressing allies to send warships to open the Strait, but Tokyo’s military actions are limited under its postwar pacifist constitution Japan could consider deploying its military for minesweeping in the Strait of Hormuz if a ceasefire is reached in the war on Iran, Japanese Minister of Foreign Affairs Toshimitsu Motegi said yesterday. “If there were to be a complete ceasefire, hypothetically speaking, then things like minesweeping could come up,” Motegi said. “This is purely hypothetical, but if a ceasefire were established and naval mines were creating an obstacle, then I think that would be something to consider.” Japan’s military actions are limited under its postwar pacifist constitution, but 2015 security legislation allows Tokyo to use its Self-Defense Forces overseas if an attack,
German Chancellor Friedrich Merz’s conservative Christian Democratic Union (CDU) yesterday faced a regional election battle in Rhineland-Palatinate, now held by the center-left Social Democratic Party (SPD). Merz’s CDU has enjoyed a narrow poll lead over the SPD — their coalition partners at the national level — who have ruled the mid-sized state for 35 years. Polling third is the far-right Alternative for Germany (AfD), which spells a greater threat to the two centrist parties in several state elections in September in the country’s ex-communist east. The picturesque state of Rhineland-Palatinate, bordering France, Belgium and Luxembourg and with a population of about 4 million,
RSS